Latest news
Loading news…
Nabi Biopharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Rockville, Maryland, United States Founded 1967 1-10 employees For Profit
Nabi Biopharmaceuticals develops preventive measures and treatments for diseases.
Nabi Biopharmaceuticals was acquired by Aviragen Therapeutics in 2012.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- NABI
- Exchange
- NASDAQ
- IPO date
- Jan 1, 2004
- Delisted
- Nov 9, 2012
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 5
- Active products
- 2
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 1967
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- HQ
- Rockville, Maryland, United States
- Region
- Washington DC Metro Area, East Coast, Southern US
- Exit date
- Jan 1, 2004
- Closed
- Jun 16, 2003
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.5
- Trend (30d)
- -0.2
- Trend (90d)
- 3.4
1
professional contacts at Nabi Biopharmaceuticals
Contact execs at Nabi Biopharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Nabi Biopharmaceuticals
Loading news…
FAQs about Nabi Biopharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.